Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > What is next?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by jopatcloon Nov 22, 2024 11:20am
29 Views
Post# 36326014

RE:RE:RE:RE:What is next?

RE:RE:RE:RE:What is next?
jopatclo wrote: Pandora see here to collect your brownie points  Grahamb, I'm sure that one of these days you'll get off your soap box. Or are you here to collect your brownie points? I noticed they have been shrinking very fast on this forum.
Pandora I put you on ignore, I looked where you post LOL same thing as your good friend GranhamB.
Continue to collect your brownie points loser Pandora I put you on ignore, I looked where you post LOL same thing as your good friend GranhamB.
Continue to collect your brownie points loser, like GranhamB the vulture you like to post here and on several of your posts that I was able to look at Pandora LOL where you have the same agenda as your great friend GranhamB (lots of posts when we are down = manipulator loser) continue to collect your brownie points loser

See MDR your double Pandora & Continue to collect your brownie points loser, like GranhamB the vulture you like to post here and on several of your posts that I was able to look at Pandora LOL where you have the same agenda as your great friend GranhamB (lots of posts when we are down = manipulator loser) continue to collect your brownie points loser

@Brotherlightness Wow what happened did I miss something this week? Last I saw we had a pretty positive PR.
@Brotherlightness Same here. Not sure how I feel about it but I added. How could we have a functioning medical device that receives praise and is approved by governing bodies and be priced at .12 this is crazy.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities